A detailed history of Tower Research Capital LLC (Trc) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 120,497 shares of MRK stock, worth $12 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
120,497
Previous 204,358 41.04%
Holding current value
$12 Million
Previous $25.3 Million 45.91%
% of portfolio
0.37%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $9.32 Million - $10.8 Million
-83,861 Reduced 41.04%
120,497 $13.7 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $18.4 Million - $19.7 Million
148,239 Added 264.15%
204,358 $25.3 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $35.8 Million - $41.7 Million
-316,145 Reduced 84.92%
56,119 $7.4 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $25.4 Million - $27.6 Million
253,535 Added 213.54%
372,264 $40.6 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $8.29 Million - $9.21 Million
80,547 Added 210.96%
118,729 $12.2 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $4.54 Million - $4.94 Million
-41,758 Reduced 52.24%
38,182 $4.41 Million
Q1 2023

May 09, 2023

BUY
$102.94 - $114.86 $1.77 Million - $1.97 Million
17,192 Added 27.4%
79,940 $8.51 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $17.8 Million - $22.8 Million
-203,184 Reduced 76.4%
62,748 $6.96 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $7.18 Million - $8.07 Million
84,998 Added 46.98%
265,932 $22.9 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $18.7 Million - $21.2 Million
-224,008 Reduced 55.32%
180,934 $16.5 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $16.9 Million - $18.9 Million
229,660 Added 131.02%
404,942 $33.2 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $6.33 Million - $7.93 Million
87,612 Added 99.93%
175,282 $13.4 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $3.71 Million - $4.09 Million
-51,822 Reduced 37.15%
87,670 $6.59 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $14.1 Million - $15.6 Million
-200,670 Reduced 58.99%
139,492 $10.8 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $17.4 Million - $20.5 Million
252,289 Added 287.11%
340,162 $26.2 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $2.09 Million - $2.32 Million
29,133 Added 49.6%
87,873 $7.19 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $2.2 Million - $2.49 Million
30,026 Added 104.57%
58,740 $4.87 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $1.43 Million - $1.62 Million
20,249 Added 239.21%
28,714 $2.22 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $531,463 - $736,634
8,388 Added 10893.51%
8,465 $652,000
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $3.32 Million - $3.75 Million
-42,844 Reduced 99.82%
77 $7,000
Q3 2019

Nov 05, 2019

BUY
$76.08 - $82.93 $3.26 Million - $3.55 Million
42,843 Added 54926.92%
42,921 $3.61 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $3.06 Million - $3.58 Million
-43,866 Reduced 99.82%
78 $7,000
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $1.53 Million - $1.75 Million
-21,994 Reduced 33.36%
43,944 $3.66 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $438,804 - $509,225
6,726 Added 11.36%
65,938 $5.04 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $4.42 Million - $5.2 Million
-76,634 Reduced 56.41%
59,212 $4.2 Million
Q2 2018

Aug 15, 2018

BUY
$50.83 - $59.72 $6.88 Million - $8.09 Million
135,446 Added 33861.5%
135,846 $8.25 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $2.75 Million - $3.19 Million
-53,935 Reduced 99.26%
400 $22,000
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $2.37 Million - $2.84 Million
46,003 Added 552.12%
54,335 $3.06 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $488,838 - $525,999
8,332
8,332 $533,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.